Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A double-blind, randomised, parallel, multicentre study

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. A, 1996, Pages 93-104

  Allegra, L ^a   Konietzko, N ^b   Leophonte, P ^c   Hosie, J ^d   Pauwels, R ^e   Guyen, J N ^f   Petitpretz, P ^g  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b RUHRLANDKLINIK   (Germany)

^c CHU RANGUEIL   (France)

^d Great Western Medical   (United Kingdom)

^e GHENT UNIVERSITY HOSPITAL   (Belgium)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; SPARFLOXACIN;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HAEMOPHILUS INFLUENZAE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT INFECTION; SPUTUM; STREPTOCOCCUS PNEUMONIAE; VITAL CAPACITY; VOMITING;

ACUTE DISEASE; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-INFECTIVE AGENTS; CLAVULANIC ACIDS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FLUOROQUINOLONES; HAEMOPHILUS INFLUENZAE; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; QUINOLONES; STREPTOCOCCUS PNEUMONIAE;

EID: 0029996632     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.1.93     Document Type: Article

References (9)

1. Anthonisen, N. R., Manfreda, J., Warren, C. P. W., Hershfield, E. S., Harding, G. K. M. & Nelson, N. A. (1987). Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Annals of Internal Medicine 106, 196-204.
2. Canton, R., Peman, J., Jimenez, M. T., Ramon, M. S. & Gobernado, M. (1992). In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrobial Agents and Chemotherapy 36, 558-65.
3. Chin, N. X., Gu, J. W., Yu, K. W., Zhang, Y. X. & Neu, H. C. (1991). In vitro activity of sparfloxacin. Antimicrobial Agents and Chemotherapy 35, 567-71.
4. Chodosh, S. (1992). Bronchitis and asthma. In Infectious Diseases (Gorbach, S. L., Bartlett, J. G., Blacklow, N. R., Eds), pp. 476-85. W. B. Saunders, Philadelphia.
5. Chow, A. W., Hall, C. B., Klein, J. O., Kammer, R. B., Meyer, R. D. & Remington, J. S. (1992). Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clinical Infectious Diseases 15, Suppl. 1, S62-88.
6. Cooper, M. A., Andrews, J. M., Ashby, J. P., Matthews, R. S. & Wise, R. (1990). In vitro activity of sparfloxacin, a new quinolone antimicrobial agent. Journal of Antimicrobial Chemotherapy 26, 667-76.
7. Honeybourne, D., Greaves, I., Baldwin, D. R., Andrews, J. M., Harris, M. & Wise, R. (1994). The concentration of sparfloxacin in lung tissues after single and multiple oral doses. International Journal of Antimicrobial Agents 4, 151-5.
8. Isada, C. M. & Stoller, J. K. (1994). Chronic bronchitis: role of antibiotics. In Respiratory Infections (Niederman, M. S., Sarosi, G. A. & Glassroth, J., Eds), pp. 621-34. W. B. Saunders, Philadelphia.
9. Shimada, J., Nogita, T. & Ishibashi, Y. (1993). Clinical pharmacokinetics of sparfloxacin. Clinical Pharmacokinetics 25, 358-69.